The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index; 1 of the 6 sources its claims cite were checked for support.
Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man
Open accessAbstract
The steady-state basal plasma glucose and insulin concentrations are determined by their interaction in a feedback loop. A computer-solved model has been used to predict the homeostatic concentrations which arise from varying degrees beta-cell deficiency and insulin resistance. Comparison of a patient's fasting values with the model's predictions allows a quantitative assessment of the contributions of insulin resistance and deficient beta-cell function to the fasting hyperglycaemia (homeostasis model assessment, HOMA). The accuracy and precision of the estimate have been determined by comparison with independent measures of insulin resistance and beta-cell function using hyperglycaemic and euglycaemic clamps and an intravenous glucose tolerance test. The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (Rs = 0.88, p less than 0.0001), the fasting insulin concentration (Rs = 0.81, p less than 0.0001), and the hyperglycaemic clamp, (Rs = 0.69, p less than 0.01). There was no correlation with any aspect of insulin-receptor binding. The estimate of deficient beta-cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (Rs = 0.61, p less than 0.01) and with the estimate from the intravenous glucose tolerance test (Rs = 0.64, p less than 0.05). The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for beta-cell deficit) limits its use, but the correlation of the model's estimates with patient data accords with the hypothesis that basal glucose and insulin interactions are largely determined by a simple feed back loop.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
15 Own result · 7 Own interpretation · 3 No full text of the sources · 1 Partly supported · 1 No basis given · accuracy not yet measured
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The fasting plasma insulin concentration is largely determined by the glucose concentration [3]”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
What the sources say
- Partly supportedcites [3] McCarthy ST, Harris F, Turner RC (1977) Glucose control of basal insulin secretion in diabetes. Diabetologia 13: 93?97 sourceExperimental — accuracy not yet measured
The Results and Discussion (page unavailable in our copy) show that changing plasma glucose affects basal insulin secretion. But they also report markedly impaired responses in diabetic subjects, including cases where insulin remained nearly constant despite a substantial glucose decrease. The paper therefore supports glucose as an influence, but not the unqualified claim that it largely determines fasting insulin concentration. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of deficient/3cell function obtained by homeostasis model assessment correlated with that derived using the hyperglycaemic clamp (R~ = 0.61, p< 0.01)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The estimate of insulin resistance obtained by homeostasis model assessment correlated with estimates obtained by use of the euglycaemic clamp (R~=0.88,p<0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“There was no correlation with any aspect of insulin-receptor binding.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“the fasting insulin concentration (P~ = 0.81, p < 0.0001)”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 32%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Reproducibility of estimate of /3-cell function by HOMA
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“in both groups together (1% 0.61, p < 0.01 : Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Comparisons of methods of assessing ~3-cell function
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and with the estimate from the intravenous glucose tolerance test (R~ = 0.64, p < 0.05).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“and in both groups together: 1% = 0.64, p< 0.05; Fig. 3).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with intravenous glucose tolerance test.
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Neither receptor numbers or any aspect of high or low affinity binding correlated with other measures of insulin resistance (HOMA, clamp, basal insulin or CIGMA: ~ all < 0.55; NS).”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
- It may state two separate claims as one. 2
- The quote only partly states this claim. 1
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The low precision of the estimates from the model (coefficients of variation: 31% for insulin resistance and 32% for/3-cell deficit) limits its use”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Summary.
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mean coefficient of variation over the two studies was 31%.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Hyperglycaemic clamp : ~-cell function (%)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The quote only partly states this claim.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“The degree of the hyperglycaemia does not correlate significantly with either the degrees of abnormal fl-cell function or insulin resistance.”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Discussion
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- The authors state this as an assumption: Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
- Rests on an assumption: The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
The authors state this as an assumption.
Normal-weight normal subjects aged <35 years have 100% beta-cell function and an insulin resistance of 1.
“Assuming that normal-weight normal subjects aged < 35 years have 100% r-cell function, and an insulin resistance of 1, the values for a patient can be assessed from the insulin and glucose concentrations by the formulae: r-cell”
The paper relies on this without support.
The plasma glucose:insulin response for normal subjects is equivalent to the C-peptide response and is insulin = 5 (glucose-3.5).
“The plasma glucose:insulin response for normal subjects, equivalent to the C-peptide response, is insulin = 5 (glucose-3.5).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Surrogate markers of peripheral insulin activity, such as homeostasis model assessment and whole-body insulin sensitivity indexes, could be useful as well in the early identification of patients with IR, before overt DM sets in ().”
From Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management (2017) · cites this paper as [240]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“After the unprocessed diet, fasting glucose and insulin levels tended to decrease compared to baseline and the homeostasis model assessment of insulin resistance (HOMA-IR) (Matthews et al., 1985) was significantly decreased compared to baseline.”
From Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain: An Inpatient Randomized Controlled Trial of Ad Libitum Food Intake (2019) · cites this paper as Matthews et al., 1985
The cited source says what the claim attributes to it.
In the citing paper
“The Homeostasis Model Assessment of Insulin Resistance (HoMA-IR) was calculated according to Matthews et al. [25].”
From Chronotype: A Tool to Screen Eating Habits in Polycystic Ovary Syndrome? (2022) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“AAV9-mTERT treated mice also showed a trend for an improved glucose uptake and a better homeostatic model assessment (HOMA (Heikkinen et al, 2007; Matthews et al, 1985)) compared to the AAV9-eGFP controls, although differences did not reach statistical significance (Supporting Information Fig S4D and E).”
From Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer (2012) · cites this paper as Matthews et al, 1985
In the citing paper
“ndirect estimates of insulin resistance, such as HOMA-IR 63 and QUICKI, 64 are derived from fasting S-insulin and glucose concentrations and have been widely used in both nondiabetic and type 2 diabetic subjects as surrogates of insulin sensitivity.65,66”
From Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes. (2008) · cites this paper as [63]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > Subjects and procedures
“The same 12 normal subjects and 11 Type 2 diabetic patients came to the hospital fasting on a separate day for a continuous infusion”
§ Homeostasis model assessment: insulin resistance and fl-cell function from fasting plasma glucose and insulin concentrations in man > HOMA compared with the hyperglycaemic clamp. The
“HOMA compared with CIGMA.The HOMA estimate of insulin resistance from the mean of 15 stressed fasting samples before the CIGMA correlated with that measured by CIGMA in 11 normal subjects (R~ = 0.69, p < 0.02), in 12 diabetic subjects (R~ 0.97, p < 0.0001)”
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Quantitative estimation of insulin sensitivity.
Bergman, R. N., Ider, Y. Z., Bowden, C. R., & Cobelli, C. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.236.6.e667 · Cited by 1,874 · cited 1×
“This use of modelling to provide a reference graph contrasts with other models where an individual patient's data have to be entered into a computer to determine the relationships between rapidly changing variables, such as occur after an intravenous glucose test [19].”
Method[WHO Expert Committee on diabetes mellitus].
Reitsma, W. D., & Terpstra, J. (1981) · PubMed · Cited by 556
Turner, R. C., Holman, R. R., Matthews, D., Hockaday, T. D. R., & Peto, J. (1979) · Metabolism · doi:10.1016/0026-0495(79)90146-x · Cited by 388
Self-citationCharacteristics of Human Erythrocyte Insulin Receptors
Gambhir, K. K., Archer, J. A., & BRADLEY, C. J. (1978) · Diabetes · doi:10.2337/diab.27.7.701 · Cited by 290
The Insulin Receptor: Its Role in Insulin Resistance of Obesity and Diabetes
Olefsky, J. M. (1976) · Diabetes · doi:10.2337/diab.25.12.1154 · Cited by 289
Hosker, J. P., Matthews, D. R., Rudenski, A. S., Burnett, M. A., Darling, P., Bown, E. G., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280882 · Cited by 287
Self-citationPulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery
Matthews, D. R., Naylor, B. A., Jones, R., Ward, G. M., & Turner, R. C. (1983) · Diabetes · doi:10.2337/diab.32.7.617 · Cited by 256
Self-citationControl of pulsatile insulin secretion in man
Matthews, D. R., Lang, D. A., Burnett, M. A., & Turner, R. C. (1983) · Diabetologia · doi:10.1007/bf00282705 · Cited by 175
Self-citationTHE BASAL PLASMA GLUCOSE: A SIMPLE RELEVANT INDEX OF MATURITY‐ONSET DIABETES
HOLMAN, R. R., & TURNER, R. C. (1981) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1981.tb00196.x · Cited by 64
Self-citation
Research works printed but not linked: 2
- Metropolitan Life Assurance Co (1959) Net weight standard for men and women. Stat Bull Metrol Life Found 40: 1?4
- Matthews DR, Hosker JP (1984) An unbiased, flexible computer programme for glucose clamping, with graphics and running statistics. Diabetologia 27: 308?309 A
Cited by
Sorted by citations
Items 10,001–10,100 of 31,469
Pérez, N., Serra, A., Granada, M. L., Rull, M., Alastrué, A., Navarro-Díaz, M., Romero, R., & Fernández-Llamazares, J. (2009) · Obesity Surgery · doi:10.1007/s11695-009-0035-0 · Cited by 36
Yang, Z., Wen, J., Qin, L., Tao, X., Ye, Z., He, M., Zhang, W., Huang, Y., Chen, L., Ling, C., et al. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.001 · Cited by 35
Relationship between vaspin gene expression and abdominal fat distribution of Korean women
Lee, J. A., Park, H. S., Song, Y. S., Jang, Y. J., Kim, J.-H., Lee, Y. J., & Heo, Y.-S. (2011) · Endocrine Journal · doi:10.1507/endocrj.k11e-073 · Cited by 36
Nishimura, H., Sanaka, T., TANIHATA, Y., Naito, T., Higuchi, C., & Otsuka, K. (2008) · Hypertension Research · doi:10.1291/hypres.31.1611 · Cited by 36
Circadian variability of blood pressure in obese children
Török, K., Pálfi, A., Szelényi, Z., & Molnár, D. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.02.012 · Cited by 36
Sasaki, H., Kawasaki, T., Ogaki, T., Kobayashi, S., Itoh, K., Yutaka, Y., Sharma, S., & Acharya, G. P. (2004) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2004.06.012 · Cited by 36
Ishikawa, T., Shiratsuki, S., Matsuda, T., Iwamoto, T., Takami, T., Uchida, K., Terai, S., Yamasaki, T., & Sakaida, I. (2013) · Journal of Gastroenterology · doi:10.1007/s00535-013-0893-z · Cited by 37
Insulin Resistance in Latent Autoimmune Diabetes of Adulthood
Behme, M. T., Dupré, J., Harris, S. B., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1288.062 · Cited by 36
Increased Insulin Resistance and Serum Resistin in Korean Patients with Behçet's Disease
Kim, S., Choe, J., Park, S., et al. (2010) · Archives of Medical Research · doi:10.1016/j.arcmed.2010.05.008 · Cited by 36
Effects of Sitagliptin on Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Rats
Beysel, S., Değertekin, C. K., Yılmaz, G., Çakır, N., Arslan, M., & Törüner, F. B. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0128 · Cited by 36
Visceral obesity modulates the impact of apolipoprotein C3 gene variants on liver fat content
Peter, A., Kantartzis, K., Machicao, F. E., Machann, J., Wagner, S., Templin, S., Königsrainer, I., Königsrainer, A., Schick, F., Fritsche, A., et al. (2011) · International Journal of Obesity · doi:10.1038/ijo.2011.154 · Cited by 37
Glucoregulatory Physiology in Subjects with Low-Normal, High-Normal, or Impaired Fasting Glucose
Dagogo-Jack, S. E., Askari, H., & Tykodi, G. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1348 · Cited by 40
Enigk, U., Breitfeld, J., Schleinitz, D., Dietrich, K., Halbritter, J., Fischer‐Rosinsky, A., Enigk, B., Müller, I., Spranger, J., Pfeiffer, A. F. H., et al. (2011) · Pharmacogenomics · doi:10.2217/pgs.11.69 · Cited by 43
Haugaard, S. B., Andersen, O., Pedersen, S. B., Dela, F., Richelsen, B., Nielsen, J. O., Madsbad, S., & Iversen, J. (2005) · Journal of Medical Virology · doi:10.1002/jmv.20410 · Cited by 36
Kim, W. T., Yun, S. J., Choi, Y. D., Kim, G., Moon, S., Choi, Y. H., Kim, I. Y., & Kim, W. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.9.1214 · Cited by 36
Bik, W., Baranowska-Bik, A., Wolińska‐Witort, E., Chmielowska, M., Martyńska, L., & Baranowska, B. (2007) · Gynecological Endocrinology · doi:10.1080/09513590701260169 · Cited by 36
Alghasham, A., & Barakat, Y. A. (2008) · Saudi Medical Journal · doi:10.15537/1658-3175.4217 · Cited by 36
Sesti, G., Fiorentino, T. V., Hribal, M. L., Sciacqua, A., & Perticone, F. (2013) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2013.01.006 · Cited by 36
Subjective Sleep Complaints Are Associated With Insulin Resistance in Individuals Without Diabetes
Pyykkönen, A.-J., Isomaa, B., Pesonen, A., Eriksson, J. G., Groop, L., Tuomilehto, J., & Räikkönen, K. (2012) · Diabetes Care · doi:10.2337/dc12-0348 · Cited by 37
Grauballe, M. B., Østergaard, J. A., Schou, S., et al. (2015) · Journal Of Clinical Periodontology · doi:10.1111/jcpe.12442 · Cited by 36
Progesterone increases skeletal muscle mitochondrial H2O2emission in nonmenopausal women
Kane, D. A., Lin, C., Anderson, E. J., Kwak, H., Cox, J. H., Brophy, P. M., Hickner, R. C., Neufer, P. D., & Cortright, R. N. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00389.2010 · Cited by 37
Derosa, G., Maffioli, P., D’Angelo, A., Salvadeo, S., Ferrari, I., Fogari, E., Gravina, A., Mereu, R., Randazzo, S., & Cicero, A. F. G. (2009) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656560902865601 · Cited by 36
Effect of Specific Allergen Inhalation on Serum Adiponectin in Human Asthma
Sood, A., Qualls, C., Seagrave, J., et al. (2008) · CHEST Journal · doi:10.1378/chest.08-1705 · Cited by 36
Prada, P. O., Coêlho, M. S., Zecchin, H. G., Dolnikoff, M. S., Gasparetti, A. L., Furukawa, L. N. S., Saad, M. J. A., & Heimann, J. C. (2005) · Journal of Endocrinology · doi:10.1677/joe.1.06028 · Cited by 36
Salas‐Salvadó, J., Granada, M., Bulló, M., Corominas, A., Casas‐Agustench, P., & Foz, M. (2007) · Metabolism · doi:10.1016/j.metabol.2007.06.014 · Cited by 36
C-Peptide and its Correlation to Parameters of Insulin Resistance in the Metabolic Syndrome
Banu, S., Jabir, N. R., Manjunath, C. N., Shakil, S., & Kamal, M. A. (2011) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152711799219271 · Cited by 36
Cho, Y., Lee, S., Jee, S. H., & Kim, J. (2015) · Annals of Laboratory Medicine · doi:10.3343/alm.2015.35.6.586 · Cited by 36
Do We Know What Homeostasis Model Assessment Measures?
Boyko, E. J., & Jensen, C. C. (2007) · Diabetes Care · doi:10.2337/dc07-1248 · Cited by 36
Tso, T. K. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kel082 · Cited by 36
Holzinger, U., Kitzberger, R., Fuhrmann, V., et al. (2007) · European Journal of Anaesthesiology · doi:10.1017/s0265021507001111 · Cited by 36
Prázný, M., Ježková, J., Horová, E., Lazárová, V., Hána, V., Kvasnička, J., Pecen, L., Marek, J., Škrha, J., & Kršek, M. (2008) · Physiological Research · doi:10.33549/physiolres.931126 · Cited by 36
Juraschek, S. P., McAdams‐DeMarco, M., Gelber, A. C., Sacks, F. M., Appel, L. J., White, K. J., & Miller, E. R. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39527 · Cited by 37
Zeghari, N., Younsi, M. O., Meyer, L., Donner, M., Drouin, P., & Ziegler, O. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801459 · Cited by 36
Gene‐specific DNA methylation may mediate atypical antipsychotic‐induced insulin resistance
Burghardt, K. J., Goodrich, J. M., Dolinoy, D. C., & Ellingrod, V. L. (2016) · Bipolar Disorders · doi:10.1111/bdi.12422 · Cited by 36
Gianuzzi, X., Palma-Ardiles, G., Hernández-Fernández, W., Pasupuleti, V., Hernández, A. V., & Pérez-López, F. R. (2016) · Maturitas · doi:10.1016/j.maturitas.2016.08.012 · Cited by 36
Bellia, A., Iellamo, F., Carli, E., Andreadi, A., Padua, E., Lombardo, M., Annino, G., Campoli, F., Tartaglione, S., D'Ottavio, S., et al. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.06.065 · Cited by 36
Zhao, X., Wang, D., Qin, L., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.12.073 · Cited by 36
INSULIN RESISTANCE SYNDROME IN AUSTRALIAN ABORIGINAL PEOPLE
Rowley, K., Best, J. D., McDermott, R. A., Green, E. A., Piers, L. S., & O’Dea, K. (1997) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.1997.tb02131.x · Cited by 37
Dias, J. P., Ismael, M. A., Pilon, M., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707388 · Cited by 36
Palomba, S. (2004) · Human Reproduction · doi:10.1093/humrep/deh053 · Cited by 36
Au, W. Y., Lam, W., Chu, C. W., Tam, S., Wong, W. K. T., Pennell, D. J., Lie, A. K. W., & Liang, R. H. S. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.09.027 · Cited by 35
Impact of Metabolic Syndrome on Brachial-Ankle Pulse Wave Velocity in Japanese
Tsubakimoto, A., Saito, I., Mannami, T., Naito, Y., Nakamura, S., Dohi, Y., & Yonemasu, K. (2006) · Hypertension Research · doi:10.1291/hypres.29.29 · Cited by 36
Blakesmith, S. J., Lyons‐Wall, P., George, C., Joannou, G. E., Petocz, P., & Samman, S. (2003) · British Journal Of Nutrition · doi:10.1079/bjn2002807 · Cited by 36
Genetic Variation in the Human Winged Helix/Forkhead Transcription Factor Gene FOXC2 in Pima Indians
Kovacs, P. L., Lehn‐Stefan, A., Stümvoll, M., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1292 · Cited by 36
Lund, S. S., Tarnow, L., Frandsen, M., Smidt, U., Pedersen, O. B., Parving, H., & Vaag, A. A. (2008) · European Journal of Endocrinology · doi:10.1530/eje-07-0500 · Cited by 34
Petit, J., Duong, M., Florentin, E., Duvillard, L., Chavanet, P., Brun, J. M., Portier, H., Gambert, P., & Vergès, B. L. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300041-jlr200 · Cited by 37
Lawlor, D. A., Riddoch, C., Page, A. S., Anderssen, S. A., Froberg, K., Harro, M., Stansbie, D., & Smith, G. D. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01551.x · Cited by 36
van Wijk, J. P. H., Cabezas, M. C., Halkes, C. J. M., & Erkelens, D. W. (2001) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/74.2.171 · Cited by 36
QUICKI Does Not Accurately Reflect Changes in Insulin Sensitivity with Exercise Training
Duncan, G. E., Hutson, A. D., & Stacpoole, P. W. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.9.7830 · Cited by 37
Anan, F., Takahashi, N., Ooie, T., et al. (2004) · Metabolism · doi:10.1016/j.metabol.2003.12.021 · Cited by 36
Goodarzi, M. O., Erickson, S. W., Port, S. C., Jennrich, R. I., & Korenman, S. G. (2003) · Metabolism · doi:10.1016/s0026-0495(03)00031-3 · Cited by 36
Comparison of pioglitazone and metformin efficacy using homeostasis model assessment
Nagasaka, S., Aiso, Y., Yoshizawa, K., & Ishibashi, S. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01083.x · Cited by 36
Vuagnat, A., Giacchè, M., Hopkins, P. N., Azizi, M., Hunt, S. C., Vedie, B., Corvol, P. L., Williams, G. H., & Jeunemaı̂tre, X. (2001) · Journal of Molecular Medicine · doi:10.1007/s001090100205 · Cited by 36
Matsubara, M., Chiba, H., Maruoka, S., & Katayose, S. (2000) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat1994.7.231 · Cited by 36
Webster, J. M., Stewart, M. W., Al‐Maskari, M., Osman, I., Kendall-Taylor, P., Mitcheson, J., & Laker, M. F. (1997) · Atherosclerosis · doi:10.1016/s0021-9150(97)00110-x · Cited by 36
Taskin, M. I., Bulbul, E., Adali, E., Hismiogulları, A. A., & Inceboz, U. (2015) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.03.006 · Cited by 36
Fuller-Rowell, T. E., Homandberg, L. K., Curtis, D. S., Tsenkova, V. K., Williams, D. R., & Ryff, C. D. (2019) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2019.04.020 · Cited by 35
“…study of Hispanic adults in the United States reported significant associations between chronic stress, fasting glucose, and glucose tolerance (McCurley et al., 2015), while a population study of Scandinavian adults found that stressful life events predicted glucose regulation and metabolic…”
Sadeghian, M., Hosseini, S. A., Zare Javid, A., Ahmadi Angali, K., & Mashkournia, A. (2021) · Obesity Surgery · doi:10.1007/s11695-020-05202-y · Cited by 35
Cicero, A. F. G., Colletti, A., Fogacci, F., Bove, M., Rosticci, M., & Borghi, C. (2017) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-016-0163-2 · Cited by 35
Hirano, T., Nishioka, F., & Murakami, T. (2004) · Metabolism · doi:10.1016/j.metabol.2003.10.021 · Cited by 34
Novel effects of hormonal contraceptive use on the plasma proteome
Josse, A. R., Garcia-Bailo, B., Fischer, K., & El-Sohemy, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045162 · Cited by 35
“We calculated insulin resistance and b cell function using the homeostasis model assessment (HOMA) method [30].”
MethodNapora, J. K., Short, R. G., Muller, D. C., Carlson, O. D., Odetunde, J. O., Xu, X., Carducci, M., Travison, T. G., Maggio, M., Egan, J. M., et al. (2011) · Journal of Andrology · doi:10.2164/jandrol.110.010983 · Cited by 35
Osima, M., Kral, R., Borgen, T. T., Høgestøl, I. K., Joakimsen, R. M., Eriksen, E. F., & Bjørnerem, Å. (2017) · Bone · doi:10.1016/j.bone.2017.01.037 · Cited by 39
Cheng, F., Dun, Y., Cheng, J., Ripley-Gonzalez, J. W., Jiang, W., You, B., & Liu, S. (2022) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2022.02.058 · Cited by 36
Roach, L. A., Meyer, B. J., Fitton, J. H., & Winberg, P. C. (2022) · Marine Drugs · doi:10.3390/md20080500 · Cited by 35
A natural history study of paediatric non-alcoholic fatty liver disease over 10 years
Draijer, L. G., Voorhoeve, M., Troelstra, M., Holleboom, A. G., Beuers, U. H., Kusters, M., Nederveen, A. J., Benninga, M. A., & Koot, B. G. P. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100685 · Cited by 35
Hammel, M. C., Stein, R., Kratzsch, J., Vogel, M., Eckert, A. J., Triatin, R. D., Colombo, M., Meigen, C., Baber, R., Staník, J., et al. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100652 · Cited by 41
Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults
Yoon, J., Heo, S., Lee, J., Kwon, Y., & Lee, J. E. (2023) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-023-01214-7 · Cited by 35
Insulin resistance, metabolic syndrome and polycystic ovaries: an intriguing conundrum
Prosperi, S., & Chiarelli, F. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1669716 · Cited by 58
Bomer, I., Sauré, C., Caminiti, C., Ramos, J. G., Zuccaro, G. N., Brea, M., Bravo, M., & Maza, C. (2015) · Journal of Pediatric Endocrinology and Metabolism · doi:10.1515/jpem-2015-0167 · Cited by 35
Koot, B. G. P., van der Baan‐Slootweg, O. H., Vinke, S., et al. (2015) · International Journal of Obesity · doi:10.1038/ijo.2015.175 · Cited by 35
Schroeder, N., Park, Y. H., Kang, M., Kim, Y., Ha, G. K., Kim, H.-R., Yates, A. A., & Caballero, B. H. (2015) · Journal of the Academy of Nutrition and Dietetics · doi:10.1016/j.jand.2015.03.023 · Cited by 37
Bhowmik, B., Afsana, F., Siddiquee, T., Munir, S. B., Sheikh, F., Wright, E., Bhuiyan, F. R., Ashrafuzzaman, S. M., Mahtab, H., Khan, A. K. A., et al. (2014) · Journal of Diabetes Investigation · doi:10.1111/jdi.12268 · Cited by 36
Zeng, T., Liu, F.-M., Zhou, J., Pan, S.-X., Xia, W., & Chen, L. (2015) · Endocrine Journal · doi:10.1507/endocrj.ej15-0046 · Cited by 37
Dugan, C. E., Barona, J., & Fernández, M. L. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2013.0109 · Cited by 35
Lucero, D., Sviridov, D. O., Freeman, L. A., Lopez, G. I., Fassio, E., Remaley, A. T., & Schreier, L. E. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.07.019 · Cited by 36
Metkus, T., Timpone, J., Leaf, D., Goetz, M. B., Harris, W., & Brown, T. (2013) · HIV Medicine · doi:10.1111/hiv.12046 · Cited by 34
Circulating irisin levels are associated with lipid and uric acid metabolism in a Chinese population
Tang, S., Zhang, R., Jiang, F., Wang, J., Chen, M., Peng, D., Yan, J. Y., Wang, S., Bao, Y., Hu, C., et al. (2015) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.12439 · Cited by 37
Perl, S., Schmoelzer, I., Sourij, H., Pressl, H., Eder, M., Zweiker, R., & Wascher, T. C. (2009) · International Journal of Cardiology · doi:10.1016/j.ijcard.2008.10.048 · Cited by 35
Interactions of Lipid Genetic Risk Scores With Estimates of Metabolic Health in a Danish Population
Justesen, J. M., Allin, K. H., Sandholt, C. H., Borglykke, A., Krarup, N. T., Grarup, N., Linneberg, A. R., Jørgensen, T., Hansen, T. F., & Pedersen, O. B. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.114.000637 · Cited by 35
Effect of Gastric Bypass Versus Diet on Cardiovascular Risk Factors
Raffaelli, M., Guidone, C., Callari, C., Iaconelli, A., Bellantone, R. D. A., & Mingrone, G. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31829d6989 · Cited by 36
Glucocorticoids and insulin resistance in children with acute lymphoblastic leukemia
Chow, E. J., Pihoker, C., Friedman, D. L., Lee, S. J., McCune, J. S., Wharton, C. M., Roth, C. L., & Baker, K. S. (2012) · Pediatric Blood & Cancer · doi:10.1002/pbc.24364 · Cited by 35
Strollo, F., Strollo, G., Morè, M., Magni, P., Macchi, C., Masini, M. A., Carucci, I., Celotti, F., Ruscica, M., & Gentile, S. (2013) · The Aging Male · doi:10.3109/13685538.2013.773305 · Cited by 35
Kangas, P., Tikkakoski, A., Tahvanainen, A., Leskinen, M. H., Viitala, J. M., Kähönen, M. A. P., Kööbi, T., Niemelä, O. J., Mustonen, J. T., & Pörsti, I. H. (2013) · Metabolism · doi:10.1016/j.metabol.2013.02.009 · Cited by 35
The Synergistic Effects of HIV, Diabetes, and Aging on Cognition
Vance, D. E., Fazeli, P. L., Dodson, J. E., Ackerman, M. L., Talley, M. H., & Appel, S. J. (2014) · Journal of Neuroscience Nursing · doi:10.1097/jnn.0000000000000074 · Cited by 36
Verkest, K. R., Fleeman, L. M., Rand, J. S., & Morton, J. M. (2010) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2010.06.001 · Cited by 35
Carr, A. D., Ritzhaupt, A., Zhang, W., Zajdenverg, R., Workman, C., Gatell, J. M., Cahn, P. E., & Chaves, R. L. (2008) · AIDS · doi:10.1097/qad.0b013e328315a7a5 · Cited by 35
Abnormal Glucose Tolerance in β-Thalassemia: Assessment of Risk Factors
Hafez, M., Youssry, I., El-Hamed, F. A., & Ibrahim, A. (2009) · Hemoglobin · doi:10.1080/03630260902817131 · Cited by 36
Liu, Z., & Ho, S. C. (2011) · Maturitas · doi:10.1016/j.maturitas.2011.07.007 · Cited by 35
Distribution of the Matsuda Index in Japanese healthy subjects
Takahara, M., Katakami, N., Kaneto, H., Noguchi, M., & Shimomura, I. (2013) · Journal of Diabetes Investigation · doi:10.1111/jdi.12056 · Cited by 33
Disse, E., Bastard, J., Bonnet, F., et al. (2008) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.02.009 · Cited by 35
Touvra, A.-M., Volaklis, K. A., Spassis, A. T., Zois, C. E., Douda, H. T., Kotsa, K., & Tokmakidis, S. P. (2011) · HORMONES · doi:10.14310/horm.2002.1302 · Cited by 35
Bertoli, S., Neri, I., Trentani, C., Ferraris, C., Amicis, R. S. D., Battezzati, A., Veggiotti, P., GIORGIS, V. D., & Tagliabue, A. (2015) · Nutrition · doi:10.1016/j.nut.2015.02.017 · Cited by 35
Gallwitz, B., KAZDA, C. M., Kraus, P., Nicolay, C., & Schernthaner, G. (2011) · Acta Diabetologica · doi:10.1007/s00592-011-0319-4 · Cited by 36
Pirgon, Ö., Çekmez, F., Bilgin, H., et al. (2012) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2012.01.004 · Cited by 35
Do antipsychotics increase diabetes risk in children and adolescents?
Galling, B., & Correll, C. U. (2014) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2015.979150 · Cited by 37
Metabolic syndrome, insulin resistance and adiponectin level in patients with chronic hepatitis C.
Grigorescu, M. D., Radu, C., Crișan, D., Grigorescu, M., Serban, A., Neculoiu, D., Rusu, M., & Acalovschi, M. (2008) · PubMed · Cited by 35
Kim, C., Kim, H. ‐., Kim, E. H., Bae, S. J., & Park, J. Y. (2013) · Diabetic Medicine · doi:10.1111/dme.12201 · Cited by 35
Husemoen, L. L. N., Jørgensen, T., Borch‐Johnsen, K., Hansen, T. F., Pedersen, O. B., & Linneberg, A. R. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011735 · Cited by 35
Aging is an Inevitable Risk Factor for Insulin Resistance
Refaie, M. R., Sayed‐Ahmed, N., Bakr, A. M., Aziz, M. Y. A., Kannishi, M. H. E., & Abdel-Gawad, S. S. (2006) · Journal of Taibah University Medical Sciences · doi:10.1016/s1658-3612(06)70005-1 · Cited by 35
Metadata
- Authors
- Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C.
- Affiliations
- University of Oxford (GB)
- ORCID
- Matthews, D. R.
- Venue
- Diabetologia
- Published
- 1985-07
- Volume
- 28
- Issue
- 7
- Pages
- 412-419
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2160234571
- Cited by
- 31,502
- References
- 21
- Citations by year
- 2026: 933 · 2025: 1060 · 2024: 1240 · 2023: 1291 · 2022: 1489 · 2021: 1528 · 2020: 1424 · 2019: 1427 · 2018: 1456 · 2017: 1440 · 2016: 1481 · 2015: 1682 · 2014: 1693 · 2013: 1621 · 2012: 1518
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Medical Research Council
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- HOMA, insulin resistance, beta-cell function, fasting blood glucose, fasting insulin, hyperglycaemic clamp, euglycaemic clamp, intravenous glucose tolerance test, insulin receptor binding, type 2 diabetes
- MeSH terms
- Adult, Blood Glucose, Computers, Diabetes Mellitus, Type 2, Erythrocytes, Fasting, Homeostasis, Humans, Insulin, Insulin Resistance, Islets of Langerhans, Middle Aged, Monocytes, Receptor, Insulin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-14, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-14 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
